Bronho-munal

Roman name

Broncho-munal

The composition and the form of

1 capsule contains liofilizirovanny lizat bacteria 3.5 (P Bronho-munal for children) or 7 mg; blistere in 10 pcs.

Characteristics

Contains liofilizirovanny lizat bacteria most often causes respiratory tract infections (Streptococcus pneumoniae, Str.viridans, Str.pyogenes, Staphylococcus aureus, Moraxella catarrhalis, Haemophilus influenzae, Klebsiella pneumoniae, Kl.ozaenae).

Pharmacokinetics

The drug is a combination of its components, is a kinetic observation is not possible. All components can be traced using markers or research.

Indications

Preventing disease recidivating upper and lower respiratory tract infections (chronic bronchitis, tonzillit, pharyngitis, laringit, rhinitis, sinusit, otitis). In combination with other drugs as a therapy immunomoduliruta in infectious diseases.

Pregnancy and lactation

Not recommended. Security products during pregnancy and breastfeeding not been explored.

Contraindications

Гиперчувствительност ь to components of the preparation.

Specific guidance

The drug used in respiratory infections ways that are difficult to treat with antibiotics, as well as bacteriological complications viral diseases of the respiratory system (especially for the elderly and children).

Patient interaction

Prescribed drug interaction Bronho-munal not described.

Overdosing

Currently, the cases of drug overdose Bronho-munal were reported.

Precautions

Between receiving drug and oral vaccine is recommended four-week interval. There should be appointed agent for treatment of acute diarrheal diseases (primarily the drug), for children up to 6 months. To avoid an overdose of children should not be applied capsules for adults.

Storage conditions

In a dry place so that the temperature does not exceed 25 ° C

Shelf life

5 years

The registration

011632/01-2000

Directory → Immunotropona funds → Immunomodulators → Bronho-munal